Khilji Shahbaz Ahmad, Khan Ammar Hameed
Department of Cardiac Surgery, Punjab Institute of Cardiology, Lahore.
J Ayub Med Coll Abbottabad. 2004 Jul-Sep;16(3):25-8.
Acute renal failure (urine output <0.5 ml/kg/hr.) following cardiopulmonary bypass is an uncommon but highly lethal complication which arises in the setting of inadequate cardiac function and may be associated with multi-organ failure. Acute renal failure (ARF) after cardiopulmonary bypass occurs in about 8% of adult cardiac surgical patients with some preoperative renal impairment and in about 3-4%, of patients with normal preoperative renal parameters. This study was conducted to determine the frequency of acute renal failure after cardiopulmonary bypass operations and to find possible risks factors.
We analyzed the data of 500 consecutive patients who survived the first 24 hours after open heart surgery at Punjab Institute of Cardiology, Lahore as this is the minimum time to evaluate post-operative renal function, their morbidity, mortality and the main contributing risk factors, from July 2000 to Dec. 2000. The association between preoperative, intra-operative and postoperative variables and the development of ARF was assessed by multivariate logistic regression.
Of the 500 consecutive patients 35 (7%) patients developed acute renal failure (serum creatinine>2.5 mg/dl) and 102 (20.4%) patients developed acute renal dysfunction (serum creatinine 1.6-2.4 mg/dl). Positive risk factors noted in the development of ARF were age, raised preoperative blood urea and creatinine, diabetes mellitus, low cardiac output state, oligurea, total CPB time, total cross clamp time and significant hypotension during the procedure or during intensive care unit (ICU) stay. Mortality rate for established ARF was extremely poor (88.8%) and there were only four (4) survivors among those requiring dialysis.
Prevention of this disastrous complication appears to be better than treatment once it is fully established. However newer aggressive forms of early renal replacement/transplant therapies may have some promise.
体外循环后急性肾衰竭(尿量<0.5毫升/千克/小时)是一种不常见但致死率很高的并发症,发生于心脏功能不全的情况下,可能与多器官功能衰竭相关。体外循环后急性肾衰竭(ARF)在约8%术前有一定肾功能损害的成年心脏手术患者中发生,在术前肾功能指标正常的患者中发生率约为3 - 4%。本研究旨在确定体外循环手术后急性肾衰竭的发生率,并找出可能的危险因素。
我们分析了拉合尔旁遮普心脏病学研究所500例在心脏直视手术后存活24小时的连续患者的数据,因为这是评估术后肾功能、发病率、死亡率及主要相关危险因素的最短时间,时间跨度为2000年7月至2000年12月。通过多因素逻辑回归评估术前、术中和术后变量与ARF发生之间的关联。
在这500例连续患者中,35例(7%)发生了急性肾衰竭(血清肌酐>2.5毫克/分升),102例(20.4%)发生了急性肾功能不全(血清肌酐1.6 - 2.4毫克/分升)。ARF发生的阳性危险因素包括年龄、术前血尿素和肌酐升高、糖尿病、低心排血量状态、少尿、体外循环总时间、总阻断时间以及术中或重症监护病房(ICU)住院期间的显著低血压。确诊ARF的死亡率极高(88.8%),在需要透析的患者中仅有4例幸存者。
一旦这种灾难性并发症完全发生,预防似乎比治疗更好。然而,更新的积极的早期肾脏替代/移植治疗形式可能有一定前景。